• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
PXS
Click for more information
0.00% 8.5¢

PHARMAXIS LTD

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
PXS
Ann: US FDA Convenes Advisory Committee for Bronchitol 		26/03/19 0 148
26/03/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  148 
PXS
Company Update on CDI Clinical Trial and New Strategic Focus 		19/03/19 1 4.7K
19/03/19 Last post  newB Comments Created with Sketch.  1  Views Created with Sketch.  4.7K 
PXS
Ann: Becoming a substantial holder 		05/03/19 0 210
05/03/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  210 
PXS
Ann: Ceasing to be a substantial holder 		04/03/19 1 562
04/03/19 Last post  newB Comments Created with Sketch.  1  Views Created with Sketch.  562 
PXS
Ann: Boehringer Completes Enrollment of Phase 2A Trial in NASH 		12:05 0 362
12:05 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  362 
PXS
Ann: Pharmaxis Commences Phase 1 LOX Clinical Trial 		22/02/19 1 678
22/02/19 Last post  Mango22 Comments Created with Sketch.  1  Views Created with Sketch.  678 
PXS
Ann: Half Yearly Report and Accounts 		15/02/19 1 543
15/02/19 Last post  newB Comments Created with Sketch.  1  Views Created with Sketch.  543 
PXS
Where’s Bakkie 		09/02/19 3 1.2K
09/02/19 Last post  newB Comments Created with Sketch.  3  Views Created with Sketch.  1.2K 

See All Discussions arrow Created with Sketch.

Top Stories

Week 47 Wrap: HotCopper users' most watched; Brent lifts on Putin's scary letter; RFK dents CSL

Welcome to the end of another week. Let's start with what HotCopper users have been watching and discussing.
Scientific conference spotlights PYC's work on blindness disease treatment PYC Therapeutics Ltd will have data from its ongoing trial into a drug candidate to treat Retinitis Pigmentosa type 11 presented in Singapore
Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing Bigtincan Holdings has fielded an offer from Investcorp. But if you think it's underwhelming – consider Wall Street volumes.
To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels Put simply: if 3D Printing is a gold rush, Amaero is selling shovels. Or maybe it's more like sneakers in an arms race.
Sales growth pushes Lovisa's fortunes (and shares) upwards Lovisa Holdings Ltd has seen its shares rise more than 2% following a sales update, and on a good day for the consumer discretionary sector
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.